Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04439032 · ClinicalTrials.gov registry record
Artoss Prospective Spine Registry Outcomes
A clinical trial of Spinal Fusion, sponsored by Artoss.
- Active
- Registry status
- 330
- Enrollment target
- 6
- Study locations
NCT04439032 is a study of Spinal Fusion that is active but no longer recruiting, run by Artoss. The registered enrollment target is 330 participants, below the 466-participant average among 19 other Spinal Fusion trials with a reported enrollment target (29% lower). The trial reports 6 study locations across 5 states.
The verdict
NCT04439032, a study of Spinal Fusion, is active but no longer recruiting, sponsored by Artoss.
- ACTIVE NOT RECRUITING
- Registry status
- 330 participants
- Enrollment target
- 6
- Study locations
Study Summary
This prospective registry was designed as an observational study to ascertain how commercially available NanoBone Bone Graft is being used by surgeons performing spinal fusion as well as determining relevant patient outcomes.
Conditions Studied
Interventions
- OTHER NanoBone Bone Graft Substitute
Study Locations (6)
Arizona
- OrthoArizona - Chandler
- Sonoran Spine - Tempe
California
- SENTA Clinic - San Diego
Connecticut
- Hartford Health Care - Hartford
Maryland
- OrthoBethesda - Bethesda
Mississippi
- Sam Shamsnia MD Neurosurgery - Biloxi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2020-08-03 |
| Est. Completion | 2025-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04439032
The ClinicalTrials.gov registry entry for NCT04439032 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 330 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 466-participant average among 19 other Spinal Fusion trials with a reported enrollment target (29% lower). The listed sponsor is Artoss, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Spinal Fusion appearing as the primary indexed condition, and to 1 intervention - of which NanoBone Bone Graft Substitute is the first listed.
NCT04439032 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Arizona, California, Connecticut.
Frequently Asked Questions
What is clinical trial NCT04439032 about?
NCT04439032 is a clinical study titled "Artoss Prospective Spine Registry Outcomes". This prospective registry was designed as an observational study to ascertain how commercially available NanoBone Bone Graft is being used by surgeons performing spinal fusion as well as determining relevant patient outcomes.
What is the current status of trial NCT04439032?
This trial is currently active not recruiting. The enrollment target is 330 participants. The study started on 2020-08-03. Estimated completion is 2025-06-30.
What conditions does trial NCT04439032 study?
This clinical trial studies the following conditions: Spinal Fusion.
What interventions are being tested in trial NCT04439032?
The interventions under investigation include: NanoBone Bone Graft Substitute (OTHER).
Who is sponsoring clinical trial NCT04439032?
This trial is sponsored by Artoss, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04439032 being conducted?
This trial has 6 study locations across Arizona, California, Connecticut, Maryland, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Fusion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
RECRUITING · Phase 3
-
Pulse-Width Modulation
RECRUITING · NA
-
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
RECRUITING · Phase 2
-
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
RECRUITING
-
Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery
RECRUITING · NA
-
Kids With Iron Deficiency and Scoliosis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.